Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552477 | SCV000656538 | uncertain significance | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2021-09-07 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine with serine at codon 394 of the RAPSN protein (p.Asn394Ser). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs370123138, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003133355 | SCV003813737 | uncertain significance | not provided | 2021-12-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829598 | SCV002087262 | uncertain significance | Congenital myasthenic syndrome | 2019-11-11 | no assertion criteria provided | clinical testing |